CVS Health Corporation (CVS)
After hours:
| Previous close | 69.03 |
| Open | 69.09 |
| Bid | 0.00 x 1000 |
| Ask | 0.00 x 800 |
| Day's range | 67.96 - 69.40 |
| 52-week range | 64.41 - 83.25 |
| Volume | |
| Avg. volume | 10,113,991 |
| Market cap | 86.469B |
| Beta (5Y monthly) | 0.51 |
| PE ratio (TTM) | 10.60 |
| EPS (TTM) | 6.47 |
| Earnings date | 01 May 2024 |
| Forward dividend & yield | 2.66 (3.88%) |
| Ex-dividend date | 19 Apr 2024 |
| 1y target est | 86.76 |
- Reuters
EXPLAINER-Why are US pharmacy benefit managers under fire?
Pharmacy benefit managers (PBMs) are in the crosshairs of Republicans and Democrats in Congress but have so far dodged any new litigation or reforms that had been targeted for inclusion in last month's U.S. government budget deal. Many lawmakers, drugmakers and government officials have pointed a finger at these industry middle men, suggesting they play a critical role in high prescription drug costs in the United States. The following is what you need to know about PBMs.
ZacksCVS Health (CVS) Declines More Than Market: Some Information for Investors
In the closing of the recent trading day, CVS Health (CVS) stood at $68.64, denoting a -1.58% change from the preceding trading day.
Yahoo FinanceWhy big Medicare Advantage insurers may root for Biden to lose in 2024
Insurance giants have a bigger stake in this year’s presidential election after recent moves by the Biden administration cut into the profitability of Medicare Advantage plans.
